|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
/ Unknown status临床2/3期IIT A 24-Week, Multicenter ,Double Blind, Randomized Study to Determine the Effects and Security of TwHF and MTX Treating Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chronic inflammatory disorder that may affect many synovial joints, and may cause serious disability. It has been confirmed that Tripterygium Wilfordii has effects of anti-inflammatory, immunosuppressive and cartilage protection. This is a multicenter ,double Blind, randomized study to evaluated the efficacy and safety of Tripterygium Wilfordii in treating of patients with rheumatoid arthritis (RA) and establish a prediction model for Tripterygium Wilfordii response of rheumatoid arthritis (RA).
100 项与 IL-2R x TNF-α x COX-2 x NOS2 x IL-1β 相关的临床结果
100 项与 IL-2R x TNF-α x COX-2 x NOS2 x IL-1β 相关的转化医学
0 项与 IL-2R x TNF-α x COX-2 x NOS2 x IL-1β 相关的专利(医药)